Sunday, November 1, 2026

Back to today

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

From X

@convequity

Convequity on X

$NVDA is in a bind. In our view it needs enterprise AI adoption to grow quickly, but a typical enterprise cannot afford Nvidia's GPUs and does not have the resources to build and run an Nvidia stack directly. So enterprises take the cheaper and more manageable option and access AI through the hyperscalers. They skip the large upfront cost, and they can run inference on the hyperscalers' custom ASICs, or at least have that option versus Nvidia's GPGPUs. In our view, those ASICs are the more efficient inference choice where a hyperscaler offers them. To curtail that, we think Nvidia would have to cut GPGPU prices sharply enough to make direct enterprise adoption realistic. That means lower margins. Dell ($DELL) was supposed to be the way around the bind, a channel that puts Nvidia compute in front of enterprises that will not build the stack themselves. We think Dell has mostly used the relationship to secure GPU supply and grow its own revenue and margins, not to open the smaller enterprise market Nvidia needs. Palantir ($PLTR) is still the exception on enterprise AI adoption, not on buying Nvidia compute directly. Its US commercial revenue grew 149% year on year last quarter, accelerating from 133% the quarter before. Outside Palantir and coding agents, we see little enterprise success. The bind stands. Direct enterprise adoption of Nvidia compute is still progressing very slowly, and we do not see a way out that leaves margins where they are.

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

TSOH Weekly Roundup (10/30/2026)

Markel spent $315 million repurchasing shares in Q3 as Thrive agreed to buy ADT for $7.6 billion and Hasbro cited rising adult toy demand.

AMZN Q3 FY12/26 Earnings Review

Amazon reported $201.9 billion Q3 revenue and 39% AWS growth, while $220 billion in 2026 capex drove trailing free cash flow to a $42.4…

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

X accounts we follow

Every account on this site, hand-picked.

91 accounts

Investor letters we follow

190 firms

Sectors

Ordered by how often our editor reaches for them.